Using glucocorticoids, rituzimab, or certain immunosuppressants to treat connective tissue diseases is associated with greater risks for severe COVID-19-related outcomes.

1–7 In particular, an association between some of the connective-tissue diseases and Hashimoto's thyroiditis (lymphadenoid goiter) has recently seemed likely. 6,8,9 Many reports of this ...

With the support of the Pamela and David Ott Fund and the John M. O'Quinn Foundation, The Pamela and David Ott Center of Excellence in Heritable Disorders of Connective Tissue and Ehlers-Danlos ...

Proper form serves as the foundation for strength development, protecting joints and connective tissues from unnecessary stress. Research indicates that mastering movement patterns with lighter ...

Connective tissue diseases (CTDs) increase the risk for adverse maternal and fetal outcomes during pregnancy, with varying impacts across different CTD subtypes, according to study results published ...